Sautner et al., 2022 - Google Patents
2022 update of the Austrian Society of Rheumatology and Rehabilitation nutrition and lifestyle recommendations for patients with gout and hyperuricemiaSautner et al., 2022
View HTML- Document ID
- 16027399670749987901
- Author
- Sautner J
- Eichbauer-Sturm G
- Gruber J
- Lunzer R
- Puchner R
- Publication year
- Publication venue
- Wiener klinische Wochenschrift
External Links
Snippet
Background Gout is the most frequent inflammatory joint disease in the western world and has a proven genetic background. Additionally, lifestyle factors like increasing life span and wealth, sufficient to excess nutritional status and a growing prevalence of obesity in the …
- 201000005569 gout 0 title abstract description 96
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce, e.g. shopping or e-commerce
- G06Q30/02—Marketing, e.g. market research and analysis, surveying, promotions, advertising, buyer profiling, customer management or rewards; Price estimation or determination
- G06Q30/0207—Discounts or incentives, e.g. coupons, rebates, offers or upsales
- G06Q30/0226—Frequent usage incentive systems, e.g. frequent flyer miles programs or point systems
- G06Q30/0232—Frequent usage rewards other than merchandise, cash or travel
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3475—Computer-assisted prescription or delivery of diets, e.g. prescription filling or compliance checking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sautner et al. | 2022 update of the Austrian Society of Rheumatology and Rehabilitation nutrition and lifestyle recommendations for patients with gout and hyperuricemia | |
Bly et al. | Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population | |
Toledo et al. | Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial | |
Gao et al. | Diet, urate, and Parkinson's disease risk in men | |
Webster et al. | Diet, diabetes status, and personal experiences of individuals with type 2 diabetes who self-selected and followed a low carbohydrate high fat diet | |
de Souza Filho et al. | Cardiovascular risk factors with an emphasis on hypertension in the Mura Indians from Amazonia | |
Sidahmed et al. | Development of exchange lists for M editerranean and H ealthy E ating D iets: implementation in an intervention trial | |
Tsai et al. | Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients | |
Schubert et al. | Carotid intima media thickness, atherosclerosis, and 5-year decline in odor identification: the beaver dam offspring study | |
Byham-Gray et al. | Nutrition in kidney disease | |
Salameh et al. | Case‐control study of risk factors and self‐care behaviors of foot ulceration in diabetic patients attending primary healthcare services in Palestine | |
Rebholz et al. | Diet soda consumption and risk of incident end stage renal disease | |
Kapetanovic et al. | The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden | |
Xiao et al. | Effectiveness of lifestyle and drug intervention on hypertensive patients: a randomized community intervention trial in rural China | |
Narasaki et al. | Dietary therapy for managing hyperphosphatemia | |
Hong et al. | Evaluation of the relationship between drink intake and periodontitis using KoGES data | |
Nihtilä et al. | The combined effect of individually tailored xerostomia and nutritional interventions on dry mouth among nutritionally compromised old home care clients | |
Van Parys et al. | The association between dairy intake and risk of cardiovascular disease and mortality in patients with stable angina pectoris | |
Costa Filho et al. | Independent predictors of effective blood pressure control in patients with hypertension on drug treatment in Brazil | |
Shi et al. | Use of low-protein staple foods in the dietary management of patients with stage 3–4 chronic kidney disease: a prospective case-crossover study | |
Hanick et al. | A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial | |
Goldfarb et al. | Effect of a high-citrate beverage on urine chemistry in patients with calcium kidney stones | |
Rallis | Optimizing glycemic control in type 2 diabetic patients through the use of a low-carbohydrate, high-fat, ketogenic diet: a review of two patients in primary care | |
Bientinesi et al. | Lifestyle in urology: Benign diseases | |
Kavouras et al. | Physical activity and adherence to Mediterranean diet increase total antioxidant capacity: the ATTICA study |